Wang, JunWang, Zi-YiChen, Shu-FenWang, Rong-ZeChen, Ke-LiangLu, Jia-YingXin, Jia-WeiHuang, Yu-YuanWang, Ming-YuXie, FangCheng, WeiYen, Tzu-ChenWischik, Claude MCui, MeiZuo, Chuan-TaoZhao, Qian-HuaWang, Yan-JiangYu, Jin-Tai2025-10-152025-08Wang, J, Wang, Z-Y, Chen, S-F, Wang, R-Z, Chen, K-L, Lu, J-Y, Xin, J-W, Huang, Y-Y, Wang, M-Y, Xie, F, Cheng, W, Yen, T-C, Wischik, C M, Cui, M, Zuo, C-T, Zhao, Q-H, Wang, Y-J & Yu, J-T 2025, 'Role of 18F-florzolotau PET in diagnostic and therapeutic decision-making for cognitive impairment', Alzheimer's & dementia : the journal of the Alzheimer's Association, vol. 21, no. 8, e70563. https://doi.org/10.1002/alz.705631552-5279PubMedCentral: PMC12358240https://hdl.handle.net/2164/26221We thank the patients and families for contributing to our research and for participating in this study.122122852engSDG 3 - Good Health and Well-beingF-Florzolotau PETdementiadiagnosistauopathyRC0321 Neuroscience. Biological psychiatry. NeuropsychiatryEpidemiologyHealth PolicyDevelopmental NeuroscienceClinical NeurologyGeriatrics and GerontologyCellular and Molecular NeurosciencePsychiatry and Mental healthSupplementary InformationRC0321Journal article10.1002/alz.70563